TELA Bio TELA
NASDAQ TELA
$1.18 +0.03 (+3.04%)
As of: Oct 1, 2026 · 12:12 PM EDT

TELA Bio (TELA) Short term Debt (2025)

Updated

TELA Bio (TELA) posted Short term Debt of $3.33 million for Q2 2025.

Analysis

TELA Bio (TELA) Short term Debt (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 TELA Bio 66.03 Mn -84.50 Mn 13.94 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 3.33 Mn
API Access

TELA Bio Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=TELA&period=max&api_key=YOUR_API_KEY